Sowell Financial Services LLC Supernus Pharmaceuticals, Inc. Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$26.72 - $33.19 $961 - $1,194	-36 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$24.15 - $31.45 $9,708 - $12,642	-402 Reduced 91.78%	36 $1,000
Q4 2020 Jan 13, 2021	BUY	$17.7 - $25.81 $5,487 - $8,001	310 Added 242.19%	438 $11,000
Q3 2020 Nov 12, 2020	SELL	$20.2 - $25.05 $4,484 - $5,561	-222 Reduced 63.43%	128 $3,000
Q2 2020 Aug 13, 2020	SELL	$17.09 - $24.89 $23,037 - $33,551	-1,348 Reduced 79.39%	350 $8,000
Q1 2020 May 12, 2020	SELL	$14.45 - $24.69 $16,212 - $27,702	-1,122 Reduced 39.79%	1,698 $31,000
Q4 2019 Feb 07, 2020	BUY	$19.93 - $29.13 $54,608 - $79,816	2,740 Added 3425.0%	2,820 $66,000
Q3 2019 Nov 14, 2019	BUY	$25.47 - $33.37 $2,037 - $2,669	80 New	80 $2,000

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.